Investor Presentaiton slide image

Investor Presentaiton

Q3 2023 Eliquis NBRX/TRx Share 24% 10% NBRx Share - US 21% 25% 9% 15% TRX Share - US Eliquis. apixaban 23% 13% 67% 70% 60% 64% Q3 2022 Q3 2023 ll Bristol Myers Squibb Q3 2023 Results Q3 2022 Q3 2023 Eliquis Warfarin Other NOACs Rx Source: IQVIA Not for Product Promotional Use 27
View entire presentation